31/10/2007 (Agence Europe) - On Tuesday 30 October in Luxembourg, the Council formally approved the regulation on the authorisation for the sales, monitoring and pharma-covigilance for innovative therapy products (gene, cell and tissue therapies) in line with the first-reading amendments of the European Parliament on 25 April (EUROPE 9414). (O.J.)